These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26399160)

  • 1. Brimonidine Induced Anterior Uveitis.
    Beltz J; Zamir E
    Ocul Immunol Inflamm; 2016; 24(2):128-33. PubMed ID: 26399160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brimonidine-associated uveitis - a descriptive case series.
    Hopf S; Mercieca K; Pfeiffer N; Prokosch-Willing V
    BMC Ophthalmol; 2020 Dec; 20(1):489. PubMed ID: 33334316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine.
    Clemente-Tomás R; Arciniegas-Perasso CA; Hervás-Hernandis JM; García-Ibor F; Ruiz-Del Río N; Duch-Samper AM
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Oct; 93(10):511-514. PubMed ID: 29910082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features.
    Nguyen EV; Azar D; Papalkar D; McCluskey P
    J Glaucoma; 2008; 17(1):40-2. PubMed ID: 18303383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior uveitis as a side effect of topical brimonidine.
    Byles DB; Frith P; Salmon JF
    Am J Ophthalmol; 2000 Sep; 130(3):287-91. PubMed ID: 11020406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs, Inflammation, and the Eye.
    Cunningham ET; London NJ; Moorthy R; Garg SJ; Zierhut M
    Ocul Immunol Inflamm; 2016; 24(2):125-7. PubMed ID: 27074544
    [No Abstract]   [Full Text] [Related]  

  • 7. Brimonidine-timolol fixed combination induced granulomatous inflammation of the eye.
    Carrasco MA; Schlaen BA; Zárate JO
    Int Ophthalmol; 2013 Oct; 33(5):557-60. PubMed ID: 23224363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anterior uveitis and topical brimonidine: a case report].
    Velasque L; Ducousso F; Pernod L; Vignal R; Deral V
    J Fr Ophtalmol; 2004 Dec; 27(10):1150-2. PubMed ID: 15687926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral granulomatous uveitis in an elderly female.
    Kattige J; Konana VK; Babu K
    Indian J Ophthalmol; 2019 Sep; 67(9):1391. PubMed ID: 31436179
    [No Abstract]   [Full Text] [Related]  

  • 10. [Brimonidine and acute anterior granulomatous uveitis: A case report and literature review].
    Comet A; Donnadieu B; Courjaret JC; Gascon P; Denis D; Matonti F
    J Fr Ophtalmol; 2017 Apr; 40(4):e127-e129. PubMed ID: 28336279
    [No Abstract]   [Full Text] [Related]  

  • 11. Suspected granulomatous anterior uveitis associated with brimonidine tartrate 0.2% and timolol maleate 0.5% ophthalmic solution.
    Casado A; Cabarga C; de la Fuente MA; Muñoz-Negrete FJ
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2659-60. PubMed ID: 23835755
    [No Abstract]   [Full Text] [Related]  

  • 12. Granulomatous anterior uveitis associated with 0.2% topical brimonidine.
    Cates CA; Jeffrey MN
    Eye (Lond); 2003 Jul; 17(5):670-1. PubMed ID: 12855989
    [No Abstract]   [Full Text] [Related]  

  • 13. Brimonidine induced bilateral hypertensive anterior uveitis: Case report and review of the literature.
    Boualila L; Bouirig K; El Hamidi S; Boutimzine N; Cherkaoui LO
    J Fr Ophtalmol; 2023 May; 46(5):e143-e145. PubMed ID: 36804117
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced ocular inflammation.
    Samalia P; Sims J; Niederer R
    N Z Med J; 2020 Dec; 133(1527):83-94. PubMed ID: 33332330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
    Tsujinaka A; Takai Y; Inoue Y; Tanito M
    Acta Ophthalmol; 2019 Sep; 97(6):e948-e949. PubMed ID: 30609169
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans.
    Takamura Y; Tomomatsu T; Matsumura T; Takihara Y; Kozai S; Arimura S; Yokota S; Inatani M
    J Ocul Pharmacol Ther; 2015 Jun; 31(5):282-5. PubMed ID: 25918904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
    Becker HI; Walton RC; Diamant JI; Zegans ME
    Arch Ophthalmol; 2004 Jul; 122(7):1063-6. PubMed ID: 15249377
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Brimonidine on the B Cells, T Cells, and Cytokines of the Ocular Surface and Aqueous Humor in Rat Eyes.
    Shin HY; Lee HS; Lee YC; Kim SY
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):623-6. PubMed ID: 26401980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
    Katz G; Dubiner H; Samples J; Vold S; Sall K
    JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis to topical brimonidine.
    Rajagopalan A; Rajagopalan B
    Australas J Dermatol; 2015 Aug; 56(3):235. PubMed ID: 26201375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.